WHO Finds a Governance Gap in Health AI
WHO data shows a gap between the use of AI in diagnosis and the existence of health strategies and clear accountability standards.
Listen to this article
Read by Anchor
What happened:In a late signal published on July 15, 2026, the World Health Organization and Portuguese officials brought together ministers and government representatives from 37 countries to discuss AI governance in health. The organisation says its assessment of the European region found that about two thirds of countries use AI in diagnosis, while only 8% have a dedicated health strategy and only 8% have accountability standards defining who bears responsibility when a system fails.
The lens: Global South solidarityThe meeting focused on rules, tools and people, and on ensuring that each country does not have to manage the transition alone. The figures show that system deployment may outpace the construction of institutional accountability.
Who is affected:Health ministries, regulators of medical devices and software, hospitals, insurers and clinical procurement teams.
What it means for the region:The European percentages cannot be transferred directly to the Middle East and North Africa, but they offer a useful checklist: a sector strategy, accountability rules, data governance, interoperability and workforce preparation before clinical use expands.
The practical takeaway:Before purchasing an AI-assisted diagnostic tool or renewing its contract, ask the governance team to document the decision owner, legal responsibility and route for human appeal.
Source: https://www.who.int/europe/news/item/15-07-2026-who-brings-37-countries-together-in-lisbon-to-get-ai-governance-right-and-make-it-work-for-every-patient